☆ 4.6 Article

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study

FRONTIERS IN ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT

Ana Jimenez-Ubieto et al.

Summary: In this study, we screened follicular lymphoma patients for liquid biopsy MRD biomarkers using NGS panel and found trackable mutations in a majority of the samples. We used ultra-deep sequencing to track these mutations in follow-up samples and found that positive LiqBio-MRD correlated with a higher risk of progression during treatment. The combination of LiqBio-MRD and PET/CT provided a sensitive and specific identification of patients who progressed in less than two years. This non-invasive approach should be considered in future clinical trials.

LEUKEMIA (2023)

Add to Collection

Article Oncology

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients

Hiu Ting Chan et al.

Summary: This study compared the clinical utility and sensitivity of two different approaches to ctDNA analyses in colorectal cancer patients. It found that tumor-informed ctDNA analysis was more accurate in monitoring genetic mutations compared to tumor-agnostic analysis. Serial monitoring of ctDNA allowed for the early detection of disease recurrence, with a median of 5 months earlier than radiological imaging.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Hematology

BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib

Silvia Bonfiglio et al.

Blood Advances (2023)

Add to Collection

Article Oncology

Sensitive Detection of Cell-Free Tumour DNA Using Optimised Targeted Sequencing Can Predict Prognosis in Gastro-Oesophageal Cancer

Karin Wallander et al.

Summary: In this study, the analysis of cell-free DNA as a prognostic cancer biomarker was evaluated for gastric and oesophageal cancer. The detection of cell-free DNA from the cancer was associated with a worse prognosis. The method of analysis, including tissue biopsy or analysis of blood cells, was found to be important for improving detection.

CANCERS (2023)

Add to Collection

Article Hematology

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Leo Meriranta et al.

Summary: Liquid biopsy has important clinical significance in high-risk DLBCL patients, as it can reveal hidden clinical and biological heterogeneity, predict the risk of relapse and death, and provide molecular information for treatment decisions.

BLOOD (2022)

Add to Collection

Article Oncology

Precision diagnostics in lymphomas-Recent developments and future directions

Larry Mansouri et al.

Summary: Genetics plays a crucial role in the clinical diagnostics of lymphomas, helping to subclassify the disease and stratify patient risk. Recent advancements in high-throughput sequencing technologies have provided a detailed understanding of the genomic landscape of various lymphoma entities, revealing a diverse genetic background. These studies have improved our understanding of lymphoma ontogeny and evolution and have identified potential genetic markers that can enhance lymphoma diagnostics and prognostication. However, the number of gene mutations with predictive impact for treatment selection remains limited. This review highlights clinically relevant diagnostic, prognostic, and predictive markers in lymphomas and discusses the potential of comprehensive genomic characterization for precision diagnostics and tailored therapy strategies.

SEMINARS IN CANCER BIOLOGY (2022)

Add to Collection

Review Hematology

Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?

Ryan D. Morin et al.

Summary: The term DLBCL encompasses a diverse collection of tumors, and recent molecular profiling studies have proposed new classification systems to overcome this biological heterogeneity. Challenges include applying these new systems in clinical practice, introducing genomic subtyping and precision medicine into DLBCL, and addressing the implications for current clinical practices and trials.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Hematology

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo et al.

Summary: Since 1994, the classification of lymphoid neoplasms has been continuously updated through international efforts, with recent progress driven by genomic studies. This proposal presents the International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors, which has refined diagnostic criteria and incorporated new insights from genomics.

BLOOD (2022)

Add to Collection

Review Oncology

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research

Eliza M. Lauer et al.

Summary: Circulating tumor DNA (ctDNA) profiling is a potential strategy for managing B-cell lymphoma patients. ctDNA assessment has advantages over conventional tissue biopsies as it captures the entire mutational landscape of tumors. This review provides a comprehensive overview of ctDNA detection and genotyping technologies in B-cell lymphoma, highlighting the advantages, limitations, and recent advances in sensitivity and accuracy. The potential applications of ctDNA in clinical practice and translational research are also discussed.

LEUKEMIA (2022)

Add to Collection

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Add to Collection

Article Oncology

Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study

Cecilia Arthur et al.

Summary: This study demonstrates that whole-genome sequencing of genetic information in children with ALL, combined with ddPCR quantification, can accurately assess MRD levels. In addition, cfDNA extracted from plasma and cerebrospinal fluid can provide valuable information about MRD and low-grade CNS involvement.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Meeting Abstract Hematology

Circulating Tumor DNA Clearance during Treatment As a Predictive and Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Patients Receiving First-Line Therapy

Yuqin Song et al.

BLOOD (2022)

Add to Collection

Article Oncology

Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care

Edwin Cuppen et al.

Summary: The combination of whole-genome and transcriptome sequencing (WGTS) is a comprehensive precision diagnostic test that is expected to transform diagnosis and treatment for cancer patients. However, there are barriers to the implementation and widespread adoption of this test, including considerations of utility in different cancer types, cost-effectiveness and affordability.

JCO PRECISION ONCOLOGY (2022)

Add to Collection

Article Oncology

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

David Tamborero et al.

Summary: This article presents the implementation of the Molecular Tumor Board Portal, a system that integrates and interprets genomics and clinical data to support clinical decision-making in precision oncology. The system automates the interpretation and reporting of sequencing results, reducing errors and promoting consistent decision-making and data capture. It also facilitates collaborative discussion through information-rich patient reports and interactive content.

NATURE CANCER (2022)

Add to Collection

Article Multidisciplinary Sciences

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma

Lucia Pedrosa et al.

Summary: This study investigated the genetic subtypes of diffuse large B-cell lymphoma, identified mutated genes associated with treatment outcomes and survival, and proposed a two-step genetic DLBCL classifier. Different genetic subtypes have different impacts on patients' prognosis, with patients in the ST2(2-S) group having the best clinical outcome.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Pathology

Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations

Daniel Andersson et al.

Summary: ctDNA analysis has become a relevant biomarker in cancer management, but biological and technical challenges need to be addressed before widespread clinical implementation. Analysis of multiple mutations combined with simultaneous assessment of other analytes may be a solution to improve sensitivity. Improved standardization and guidelines will facilitate the introduction of ctDNA analysis into clinical routine.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

Eric J. Duncavage et al.

Summary: This study showed that whole-genome sequencing provided rapid and accurate genomic profiling in patients with AML or MDS, with a greater diagnostic yield than conventional cytogenetic analysis, and more efficient risk stratification based on standard risk categories.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

Xue Shi et al.

Summary: The study evaluated the prognostic relevance of early risk stratification in DLBCL patients and developed a new stratification system combining an interim evaluation and IPI. The combined risk stratification system separated patients into different risk groups with significant differences in overall survival and progression-free survival rates.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients

Henrik Stranneheim et al.

Summary: The study reports findings from whole genome sequencing of 4437 individuals at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015, leading to molecular diagnoses for a portion of patients. Information sharing between teams was beneficial in clinical practice. Additionally, research resulted in the discovery of 17 new disease-causing genes.

GENOME MEDICINE (2021)

Add to Collection

Article Hematology

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma

Riccardo Moia et al.

Summary: By molecularly dissecting the anatomical heterogeneity of SLL, we found unique mutations in different compartments, with plasma ctDNA identifying additional mutations. The synchronous sources of tumor DNA complement each other in providing information on driver gene mutations in SLL, potentially offering prognostic and predictive value.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Oncology

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Matthew J. Frank et al.

Summary: This study demonstrated the prognostic value of circulating tumor DNA (ctDNA) in predicting outcomes of large B-cell lymphoma patients undergoing axicabtagene ciloleucel (axi-cel) treatment. Higher baseline ctDNA concentrations were associated with progression post-treatment and development of toxicities. Additionally, patients with undetectable ctDNA 1 week after axi-cel infusion had higher rates of durable response compared to those with detectable ctDNA.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

David M. Kurtz et al.

Summary: PhasED-seq improves the sensitivity of ctDNA detection by using multiple somatic mutations in individual DNA fragments, outperforming previous methods with better limits of detection in the ppm range. In patients with B cell lymphomas, PhasED-seq can detect more cases of ctDNA positivity associated with worse outcomes. The method is also applicable to solid tumors.

NATURE BIOTECHNOLOGY (2021)

Add to Collection

Article Oncology

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study

Alfredo Rivas-Delgado et al.

Summary: The study analyzed the utility of cfDNA in DLBCL patients to determine mutational profile and tumor burden. It found that higher levels of ctDNA were associated with clinical parameters and treatment response in DLBCL patients.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Hematology

Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study

Sara Ekberg et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Hematology

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Stuart E. Lacy et al.

BLOOD (2020)

Add to Collection

Article Oncology

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

George W. Wright et al.

CANCER CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

The mutational constraint spectrum quantified from variation in 141,456 humans

Konrad J. Karczewski et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

Ferran Nadeu et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Medicine, General & Internal

Cell-free tumour DNA testing for early detection of cancer - a potential future tool

G. Barbany et al.

JOURNAL OF INTERNAL MEDICINE (2019)

Add to Collection

Article Multidisciplinary Sciences

Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA

Vicky Rowlands et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Predicting Splicing from Primary Sequence with Deep Learning

Kishore Jaganathan et al.

CELL (2019)

Add to Collection

Article Hematology

Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma

Mahsa Eskandari et al.

BLOOD RESEARCH (2019)

Add to Collection

Article Hematology

Comprehensive detection of chromosomal translocations in lymphoproliferative disorders by massively parallel sequencing

Philippe Szankasi et al.

JOURNAL OF HEMATOPATHOLOGY (2019)

Add to Collection

Article Biochemical Research Methods

fastp: an ultra-fast all-in-one FASTQ preprocessor

Shifu Chen et al.

BIOINFORMATICS (2018)

Add to Collection

Article Oncology

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Oliver A. Zill et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Oncology

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis

Yuebi Hu et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy et al.

NATURE MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

R. Schmitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

J. Mateo et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Article Oncology

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

David M. Kurtz et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort

Elodie Bohers et al.

BLOOD CANCER JOURNAL (2018)

Add to Collection

Article Oncology

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up

Sandra Lockmer et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Hematology

Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma

Marie-Helene Delfau-Larue et al.

BLOOD ADVANCES (2018)

Add to Collection

Article Medicine, General & Internal

Genetic landscape and deregulated pathways in B-cell lymphoid malignancies

R. Rosenquist et al.

JOURNAL OF INTERNAL MEDICINE (2017)

Add to Collection

Article Pathology

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

Marilyn M. Li et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2017)

Add to Collection

Article Oncology

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma

Clementine Sarkozy et al.

ONCOTARGET (2017)

Add to Collection

Letter Oncology

Circulating Cell-free DNA Utility for the Surveillance of Patients with Treated Diffuse Large B-cell Lymphoma

M. Li et al.

CLINICAL ONCOLOGY (2017)

Add to Collection

Article Hematology

Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?

Steven Le Gouill et al.

BLOOD (2017)

Add to Collection

Article Hematology

Diffuse large B-cell lymphoma genotyping on the liquid biopsy

Davide Rossi et al.

BLOOD (2017)

Add to Collection

Article Biochemical Research Methods

Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications

Xiaoyu Chen et al.

BIOINFORMATICS (2016)

Add to Collection

Article Biochemical Research Methods

MultiQC: summarize analysis results for multiple tools and samples in a single report

Philip Ewels et al.

BIOINFORMATICS (2016)

Add to Collection

Article Oncology

Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma

Vincent Camus et al.

LEUKEMIA & LYMPHOMA (2016)

Add to Collection

Article Cell Biology

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

Florian Scherer et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Add to Collection

Article Biotechnology & Applied Microbiology

Vcfanno: fast, flexible annotation of genetic variants

Brent S. Pedersen et al.

GENOME BIOLOGY (2016)

Add to Collection

Article Biotechnology & Applied Microbiology

The Ensembl Variant Effect Predictor

William McLaren et al.

GENOME BIOLOGY (2016)

Add to Collection

Article Hematology

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

David M. Kurtz et al.

BLOOD (2015)

Add to Collection

Article Oncology

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Carla Casulo et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Oncology

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

David W. Scott et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Pathology

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma A Comparison with Real-Time PCR

Daniela Drandi et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2015)

Add to Collection

Article Oncology

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore et al.

LANCET ONCOLOGY (2015)

Add to Collection

Article Oncology

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

Mark Roschewski et al.

LANCET ONCOLOGY (2015)

Add to Collection

Article Oncology

Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study

H. R. Junlen et al.

LEUKEMIA (2015)

Add to Collection

Meeting Abstract Oncology

DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES

Chetan Bettegowda et al.

NEURO-ONCOLOGY (2014)

Add to Collection

Article Biochemical Research Methods

DELLY: structural variant discovery by integrated paired-end and split-read analysis

Tobias Rausch et al.

BIOINFORMATICS (2012)

Add to Collection

Article Biochemical Research Methods

The Sequence Alignment/Map format and SAMtools

Heng Li et al.

BIOINFORMATICS (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.